Evidence map›Paper›PMID 35757802›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Pore Strategy Design of a Novel NiTi-Nb Biomedical Porous Scaffold Based on a Triply Periodic Minimal Surface.

Yuting Lv, Guohao Liu, Binghao Wang, Yujin Tang, Zhengjie Lin, Jia Liu, Guijiang Wei, Liqiang Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Novel synthesis of AlJournal of materials science. Materials in medicine · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Bio-high entropy alloys: Progress, challenges, and opportunities.Frontiers in bioengineering and biotechnology · 2022
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yuting LvCollege of Mechanical and Electronic Engineering, Shandong University of Science and Technology, Qingdao, China.
Guohao LiuCollege of Mechanical and Electronic Engineering, Shandong University of Science and Technology, Qingdao, China.
Binghao WangCollege of Mechanical and Electronic Engineering, Shandong University of Science and Technology, Qingdao, China.
Yujin TangAffiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Zhengjie Lin3D Printing Clinical Translational and Regenerative Medicine Center, Shenzhen Shekou People's Hospital, Shenzhen, China.
Jia LiuAffiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Guijiang WeiState Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, China.
Liqiang WangState Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai, China.
Shanghai Jiao Tong University · CNAffiliated Hospital of Youjiang Medical University for Nationalities · CNShandong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pore strategy is one of the important factors affecting the biomedical porous scaffold at the same porosity. In this work, porous scaffolds were designed based on the triply periodic minimal surface (TPMS) structure under the same porosity and different pore strategies (pore size and size continuous gradient distribution) and were successfully prepared using a novel Ni

Indexed as

additive manufacturingNiTi-Nbpore strategyporous scaffoldstriply periodic minimal surfaces

Identifiers

PMID35757802
PMCPMC9214207
OpenAlexW4285744553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.